NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹71 Cr | ₹85 Cr | ₹96 Cr | ₹100 Cr | ₹90 Cr |
What is the latest Long Term Provisions ratio of NATCO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹71 Cr |
Mar2023 | ₹85 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹100 Cr |
Mar2020 | ₹90 Cr |
How is Long Term Provisions of NATCO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹71 Cr | -16.88 | |
Mar2023 | ₹85 Cr | -10.87 | |
Mar2022 | ₹96 Cr | -3.92 | |
Mar2021 | ₹100 Cr | 10.42 | |
Mar2020 | ₹90 Cr | - |
Compare Long Term Provisions of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹16,510.3 Cr | 5.8% | 7% | -20% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 5.8% |
7% |
-20% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses